PLRX compared with PMVP: revenue, margins and what each company keeps, and the suppliers and customers both name

PLRXPliant Therapeutics, Inc.

Mkt capRevenueRevenue

PMVPPMV Pharmaceuticals, Inc.

Mkt capRevenueRevenue

Compare

PLRXPliant Therapeutics, Inc.

PMVPPMV Pharmaceuticals, Inc.

Price

Mkt cap

Revenue

Supply-chain overlap

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

direct ties · both sidesSources ›

direct ties · both sides

Only PLRX 1

NVSNovartissupplier

Shared 0

No shared counterparties.

Only PMVP 1

—Foundation Medicineunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

PLRXPliant Therapeutics, Inc.

0.85▼−1.46%· post 0.85· delayed

Mkt cap$53.2MRevenue$248,000Q2 FY23

PMVPPMV Pharmaceuticals, Inc.

1.37▲+4.72%· post 1.37· delayed

After hoursNov 2 '26delayed

Mkt cap$70.0MRevenue—

Compare

After hoursNov 2 '26delayed

PLRXPliant Therapeutics, Inc.

PMVPPMV Pharmaceuticals, Inc.

0.85▼−1.46%post 0.85delayed

Price

1.37▲+4.72%post 1.37delayed

$53.2M

Mkt cap

$70.0M

Q2 FY23$248,000

Revenue

—

PLRX0.85▼−1.46%vsPMVP1.37▲+4.72%After hoursNov 2 '26delayed